Abstract
To clarify the toxicity of diborane, we conducted acute (15 ppm for 1, 2, 4 or 8h) and subacute (5 ppm for 2 or 4 weeks) inhalation studies on ICR mice. The concentration resulting in a 50% kill after 4 h exposure was 31.5 ppm. body weight gain was suppressed and the lung weight was increased in diborane-exposed mice in both acute and subacute studies. In the acute study, diffuse pan bronchiolitis-like lesions developed in the lung in various degrees depending on exposure time, which can be pathologically characterized as infiltration of inflammatory cells into the terminal bronchioles and surrounding alveoli, pulmonary congestion and bleeding and/or edema. In the subacute study, we observed lymphoid hyperplasia in the perivascular and peribronchial areas, and infiltration of macrophage and plasma cells into the alveoli. In the mice exposed for 4 weeks, the lesions were more severe than in those exposed for 2 weeks, consisting of hyperplasia and desquamation of Clara cells. In the nasal cavity, we saw mucous exudate and inflammatory cells, suggesting irritation caused by diborane. The histopathological findings, except for the respiratory organs, did not reveal any exposure-related changes. No significant changes were seen in hematological and serum biochemical examinations either. In conclusion, the target organ of diborane inhalation is the respiratory organs, particularly the lung. Further inhalation experiments are essential to investigate the safety exposure levels of diborane.
Similar content being viewed by others
References
Comitte on Threshold Limits of the American Conference of Governmental Industrial Hygienists (1955). Threshold Limit Values for 1955, A.M.A. Arch Indust Health 11: 521–524, 1955
Comstock CC, Feinsilver L, Lawson LH, Oberst FW (1954) Inhalation toxicity of diborane in dogs, rats and guinea pigs. Research reports No. 258. Chemical Corps Medical Laboratories, Army Chemical Center, MD
Hills LD, Gibson ET, Fak HC (1954) The breakdown of decaborane in protein solutions, water and alcohol. MLEE No. 324. Army Chemical Center, MD
Homma H (1971) Chronic bronchitis and chronic diffuse panbronchitis. Nippon Rynsho 29: 2636–2641
Homma H (1976) Diffuse panbronchiolitis. Jpn J Intern Med 65: 645–659
Homma H et al. (1983) Diffuse panbronchiolitis. A Disease of the transitional Zone of the Lung. CHEST Jan 63–69
Jacobson KH, Murtha EF, Weir FW et al. (1960) Spec. Pub. Chemical Research & Development Laboratories: 2–34
Jacobson KH, and Lawson LT (1962) The effects of age or weight on the toxicity of diborane. Toxicol Appl Pharmacol 4: 215–219
Krackow EH (1953) Toxicity and health hazards of boron hydrides. A.M.A. Arch Ind Hyg 8: 335
Kunkel AM, Murtha EF, Oikemus AH, Stabile DE, Saunders JP, Wills JH (1954) Some pharmacologic effects of diborane. Arch Ind Health 13: 346–351
Lowe HL, and Freeman G (1957) Borone hydride intoxication in man. A.M.A. Arch Indust Hyg Occup Med 16: 523–533
McAdams AJ (1955) The influence of spontaneous pulmonary disease in a toxico-pathological study of chronic diborane toxicity in rats. Chem Corps Med Lab Research Report No. 362.
Nihon Sanso Co (1986) The resolution analysis of diborane. Technical report, Nihon Sanso Co
Rozendaal HM (1951) Clinical Observations on the Toxicology of Boron hydrides. A.M.A. Arch Indust Hyg 4: 257–260
Safety handling manual for Specialty Gases used in semiconductor producing processes (1991) SEMI. Japan: 102–104
Wills JH (1953) Toxicity and Pharmacology of Boron Hydrides, Special Report 15, Chemical Corps Medical Laboratories, Army Chemical Center, MD
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uemura, T., Omae, K., Nakashima, H. et al. Acute and subacute inhalation toxicity of diborane in male ICR mice. Arch Toxicol 69, 397–404 (1995). https://doi.org/10.1007/s002040050190
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050190